SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Borosil Scientific gains on the BSE

25 Feb 2025 Evaluate

Borosil Scientific is currently trading at Rs 136.45, up by 1.35 points or 1.00% from its previous closing of Rs 135.10 on the BSE.

The scrip opened at Rs 135.10 and has touched a high and low of Rs 137.00 and Rs 135.05 respectively. So far 2097 shares were traded on the counter.

The BSE group 'B' stock of face value Rs 1 has touched a 52-week high of Rs 229.80 on 01-Jul-2024 and a 52-week low of Rs 130.05 on 17-Feb-2025.

Last one week high and low of the scrip stood at Rs 146.50 and Rs 134.40 respectively. The current market cap of the company is Rs 1212.39 crore.

The promoters holding in the company stood at 67.84%, while Institutions and Non-Institutions held 0.28% and 31.88% respectively.

Borosil Scientific is shifting its Ambad unit located at Nashik, Maharashtra to its own facility located at Bharuch in Gujarat. The unit is engaged in the manufacturing of pharmaceutical primary packaging such as Ampoules and Vials. The process of shifting is likely to be completed by end of March 2025. As it is merely shifting of operations from one location to another, there would be no impact on the turnover and net worth of the company. The company has received a notice from its landlord to vacate the said premises on or before April 1, 2025.

The shifting will lead to the consolidation and optimization of the company's operations related to the manufacturing of ampoules and vials.

Borosil Scientific is engaged in the business of manufacturing and trading of Scientific & Industrial Products (SIP) and manufacturing of Consumer Products (CP).


Borosil Scientific Share Price

118.05 1.70 (1.46%)
17-Apr-2026 13:39 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×